Stock Events

Stock Events

Jiangsu Hengrui Pharmaceuticals. 

€7.2
0
-€0.05-0.69% Today

Statistics

Day High
7.2
Day Low
7.15
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
47.67
Dividend Yield
-
Dividend
-

Upcoming

Earnings

20AprExpected
Q1 2025
Q2 2025
Q3 2025
Next
0.02
0.03
0.04
0.05
Expected EPS
0.04008835293969001
Actual EPS
N/A

Financials

25.68%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
3.19BRevenue
819.86MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0BO.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Shanghai Fosun Pharmaceutical (Group).
600196.SHG
Mkt Cap73.26B
Fosun Pharma offers a broad range of pharmaceutical products, directly competing in several therapeutic areas with Jiangsu Hengrui.
Yunnan Baiyao Group.
000538.SZ
Mkt Cap98.68B
Yunnan Baiyao operates in the pharmaceutical sector, offering products that compete in the traditional Chinese medicine segment against Jiangsu Hengrui's offerings.
Sichuan Kelun Pharmaceutical
002422.SZ
Mkt Cap39.2B
Jiangsu Hengrui and Kangmei Pharmaceutical compete in the pharmaceutical market, particularly in the development and manufacturing of medicine and health-related products.
Tonghua Dongbao Medicines.
600867.SHG
Mkt Cap18.82B
Tonghua Dongbao Pharmaceutical is a direct competitor in the pharmaceutical industry, focusing on insulin and other diabetes-related medicines, areas Jiangsu Hengrui is expanding into.
Zhejiang NHU.
002001.SZ
Mkt Cap55.67B
Zhejiang Medicine is a competitor in the pharmaceutical sector, with a focus on the research, development, production, and sale of pharmaceutical products, overlapping with Jiangsu Hengrui's market.
Joincare Pharmaceutical Group Industry.
600380.SHG
Mkt Cap22.15B
Jiangsu Hengrui and Harbin Pharmaceutical Group hold competitive positions in the pharmaceutical industry, particularly in the production and sale of pharmaceutical products.
Huadong Medicine.
000963.SZ
Mkt Cap81.74B
Huadong Medicine competes with Jiangsu Hengrui in the pharmaceutical sector, especially in the areas of oncology and anti-infective products.
Shenzhen Kangtai Biological Products
300601.SZ
Mkt Cap34.83B
Kanghong Pharmaceuticals is a competitor in the ophthalmology sector, a field Jiangsu Hengrui is involved in through its development of ophthalmic products.
Lepu Medical Technology (Beijing).
300003.SZ
Mkt Cap43.1B
Lepu Medical Technology competes with Jiangsu Hengrui in the healthcare sector, particularly in the development and manufacturing of medical devices and pharmaceuticals.
Shenzhen Salubris Pharmaceuticals.
002294.SZ
Mkt Cap37.85B
Sinopharm Group is a major competitor in the pharmaceutical and healthcare industry, with a broad range of products and services that compete with Jiangsu Hengrui's offerings.

About

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Show more...
CEO
Mr. Piao Yang Sun
Employees
20602
Country
CA
ISIN
CNE100006XS6
WKN
000A41984

Listings

OTC Link
US
JHPCY
HK
HK
1276.HK
F
DE
0BO.F
OTC Link
US
JNGHF

0 Comments

Share your thoughts

FAQ

What is Jiangsu Hengrui Pharmaceuticals. stock price today?▼
The current price of 0BO.F is €7.2 EUR — it has decreased by -0.69% in the past 24 hours. Watch Jiangsu Hengrui Pharmaceuticals. stock price performance more closely on the chart.
What is Jiangsu Hengrui Pharmaceuticals. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Jiangsu Hengrui Pharmaceuticals. stocks are traded under the ticker 0BO.F.
When is the next Jiangsu Hengrui Pharmaceuticals. earnings date?▼
Jiangsu Hengrui Pharmaceuticals. is going to release the next earnings report on April 20, 2026.
What were Jiangsu Hengrui Pharmaceuticals. earnings last quarter?▼
0BO.F earnings for the last quarter are 0.02 EUR per share, whereas the estimation was 0.04 EUR resulting in a -32.43% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Jiangsu Hengrui Pharmaceuticals. revenue for the last year?▼
Jiangsu Hengrui Pharmaceuticals. revenue for the last year amounts to 3.19B EUR.
What is Jiangsu Hengrui Pharmaceuticals. net income for the last year?▼
0BO.F net income for the last year is 819.86M EUR.
How many employees does Jiangsu Hengrui Pharmaceuticals. have?▼
As of April 02, 2026, the company has 20,602 employees.
When did Jiangsu Hengrui Pharmaceuticals. complete a stock split?▼
Jiangsu Hengrui Pharmaceuticals. has not had any recent stock splits.
Where is Jiangsu Hengrui Pharmaceuticals. headquartered?▼
Jiangsu Hengrui Pharmaceuticals. is headquartered in Lianyungang, CA.